Medicated Skin Care in New Zealand

Date: March 8, 2012
Pages: 36
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M616F13CE4FEN
Leaflet:

Download PDF Leaflet

During 2010, Regulatory Reform Minister, Rodney Hide, introduced the Regulatory Responsibility Bill to review and remove hundreds of regulations that are considered to hinder business practice in New Zealand. With regard to medicated skin care, this review was intended to reduce compliance costs for manufacturers and importers of ‘related products’ among other things. Related products are defined in Section 94 of the Medicines Regulations Act 1984 as ‘a product that is primarily a food,...

Euromonitor International's Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Douglas Pharmaceuticals Ltd in Consumer Health (new Zealand)
Strategic Direction
Key Facts
  Summary 1 Douglas Pharmaceuticals Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 2 Douglas Pharmaceuticals: Competitive Position 2011
Mylan New Zealand Ltd in Consumer Health (new Zealand)
Strategic Direction
Key Facts
  Summary 3 Mylan New Zealand Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 4 Mylan New Zealand Ltd: Competitive Position 2011
Executive Summary
Consumer Health Remains Buoyant During 2011
Prevention Remains A Major Focus Area
Vitaco Health Continues To Lead Sales
Direct Selling Channel Records Growth in 2011
Value Sales Expected To Increase Over Forecast Period
Key Trends and Developments
New Zealand's Ageing Population
New Zealand To Be Smoke-free by 2025
Natural Health Products Bill
Christchurch Earthquake
Natural Healing and Prevention
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Advertising
Packaging
Labelling
Distribution
Self-medication/self-care and Preventative Medicine
Switches
  Summary 5 OTC - Switches 2009-2011
Definitions
Sources
  Summary 6 Research Sources
Skip to top


Medicated Skin Care - Philippines US$ 990.00 Mar, 2010 · 39 pages
Medicated Skin Care in Portugal US$ 990.00 Sep, 2012 · 26 pages
Medicated Skin Care - Singapore US$ 990.00 Mar, 2010 · 38 pages
Medicated Skin Care in Slovakia US$ 990.00 May, 2012 · 27 pages

Ask Your Question

Medicated Skin Care in New Zealand
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: